Stemness of the hybrid epithelial/mesenchymal state in breast cancer and its association with poor survival

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Grosse Wilde, Anne ^a   D'Hérouël, Aymeric Fouquier ^a,b   McIntosh, Ellie ^a   Ertaylan, Gökhan ^b   Skupin, Alexander ^a,b   Kuestner, Rolf E ^a   Del Sol, Antonio ^b   Walters, Kathie Anne ^a   Huang, Sui ^a  

^a INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

^b UNIVERSITY OF LUXEMBOURG   (Luxembourg)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER PROGNOSIS; CANCER SURVIVAL; CELL POPULATION; CELL RENEWAL; CELL SELECTION; CONTROLLED STUDY; DISEASE ASSOCIATION; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MESENCHYME CELL; PHENOTYPE; PLASTICITY; TUMOR PROMOTION; ANIMAL; BREAST TUMOR; CANCER STEM CELL; CANCER TRANSPLANTATION; DISEASE FREE SURVIVAL; FEMALE; MESENCHYMAL STROMA CELL; METABOLISM; MORTALITY; MOUSE; NUDE MOUSE; PATHOLOGY; SURVIVAL RATE; TUMOR CELL LINE;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; DISEASE-FREE SURVIVAL; EPITHELIAL CELLS; FEMALE; HUMANS; MESENCHYMAL STROMAL CELLS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; SURVIVAL RATE;

EID: 84934914736     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0126522     Document Type: Article

References (68)

1. Medema JP. Cancer stem cells: the challenges ahead. Nat Cell Biol. 2013; 15: 338-344. doi: 10.1038/ncb2717 PMID: 23548926
2. Gupta GP, Massagué J. Cancer Metastasis: Building a Framework. Cell. 2006; 127: 679-695. doi: 10.1016/j.cell.2006.11.001 PMID: 17110329
3. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001; 414: 105-111. doi: 10.1038/35102167 PMID: 11689955
4. Shackleton M, Vaillant F, Simpson KJ, Stingl J, Smyth GK, Asselin-Labat M-L, et al. Generation of a functional mammary gland from a single stem cell. Nature. 2006; 439: 84-88. doi: 10.1038/nature04372 PMID: 16397499
5. Granit RZ, Slyper M, Ben-Porath I. Axes of differentiation in breast cancer: untangling stemness, lineage identity, and the epithelial to mesenchymal transition. Wiley Interdiscip Rev Syst Biol Med. 2014; 6: 93-106. PMID: 24741710
6. Keller PJ, Arendt LM, Skibinski A, Logvinenko T, Klebba I, Dong S, et al. Defining the cellular precursors to human breast cancer. Proc Natl Acad Sci. 2012; 109: 2772-2777. doi: 10.1073/pnas.1017626108 PMID: 21940501
7. Lim E, Vaillant F, Wu D, Forrest NC, Pal B, Hart AH, et al. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med. 2009; 15: 907-913. doi: 10.1038/nm.2000 PMID: 19648928
8. Molyneux G, Geyer FC, Magnay F-A, McCarthy A, Kendrick H, Natrajan R, et al. BRCA1 Basal-like Breast Cancers Originate from Luminal Epithelial Progenitors and Not from Basal Stem Cells. Cell Stem Cell. 2010; 7: 403-417. doi: 10.1016/j.stem.2010.07.010 PMID: 20804975
9. Li CI, Daling JR, Porter PL, Tang M-TC, Malone KE. Adjuvant hormonal therapy for breast cancer and risk of hormone receptor-specific subtypes of contralateral breast cancer. Cancer Res. 2009; 69: 6865-6870. doi: 10.1158/0008-5472.CAN-09-1355 PMID: 19706753
10. Jones RL, Constantinidou A, Reis-Filho JS. Molecular Classification of Breast Cancer. Surg Pathol Clin. 2012; 5: 701-717. doi: 10.1016/j.path.2012.06.008
11. Dontu G. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 2003; 17: 1253-1270. doi: 10.1101/gad.1061803 PMID: 12756227
12. Chen L, Xiao Z, Meng Y, Zhao Y, Han J, Su G, et al. The enhancement of cancer stem cell properties of MCF-7 cells in 3D collagen scaffolds for modeling of cancer and anti-cancer drugs. Biomaterials. 2012; 33: 1437-1444. doi: 10.1016/j.biomaterials.2011.10.056 PMID: 22078807
13. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008; 133: 704-15. doi: 10.1016/j.cell.2008.03.027 PMID: 18485877
14. Morel AP, Lievre M, Thomas C, Hinkal G, Ansieau S, Puisieux A. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PloS One. 2008; 3: e2888. doi: 10.1371/journal.pone.0002888 PMID: 18682804
15. Thiery JP, Acloque H, Huang RYJ, Nieto MA. Epithelial-Mesenchymal Transitions in Development and Disease. Cell. 2009; 139: 871-890. doi: 10.1016/j.cell.2009.11.007 PMID: 19945376
16. Tam WL, Weinberg RA. The epigenetics of epithelial-mesenchymal plasticity in cancer. Nat Med. 2013; 19: 1438-1449. doi: 10.1038/nm.3336 PMID: 24202396
17. Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer. 2009; 9: 265-273. doi: 10.1038/nrc2620 PMID: 19262571
18. Kim HJ, Kim M-J, Ahn SH, Son BH, Kim SB, Ahn JH, et al. Different prognostic significance of CD24 and CD44 expression in breast cancer according to hormone receptor status. The Breast. 2011; 20: 78-85. doi: 10.1016/j.breast.2010.08.001 PMID: 20810282
19. Mylona E, Giannopoulou I, Fasomytakis E, Nomikos A, Magkou C, Bakarakos P, et al. The clinicopathologic and prognostic significance of CD44+/CD24-/low and CD44-/CD24+ tumor cells in invasive breast carcinomas. Hum Pathol. 2008; 39: 1096-1102. doi: 10.1016/j.humpath.2007.12.003 PMID: 18495204
20. Patsialou A, Wang Y, Lin J, Whitney K, Goswami S, Kenny PA, et al. Selective gene-expression profiling of migratory tumor cells in vivo predicts clinical outcome in breast cancer patients. Breast Cancer Res BCR. 2012; 14: R139. doi: 10.1186/bcr3344
21. Kim J, Villadsen R, Sorlie T, Fogh L, Gronlund SZ, Fridriksdottir AJ, et al. Tumor initiating but differentiated luminal-like breast cancer cells are highly invasive in the absence of basal-like activity. Proc Natl Acad Sci. 2012; 109: 6124-6129. doi: 10.1073/pnas.1203203109 PMID: 22454501
22. Taube JH, Herschkowitz JI, Komurov K, Zhou AY, Gupta S, Yang J, et al. Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc Natl Acad Sci. 2010; 107: 15449-15454. doi: 10.1073/pnas.1004900107 PMID: 20713713
23. Korpal M, Ell BJ, Buffa FM, Ibrahim T, Blanco MA, Celià-Terrassa T, et al. Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. Nat Med. 2011; 17: 1101-1108. doi: 10.1038/nm.2401 PMID: 21822286
24. Ocaña OH, Córcoles R, Fabra Á, Moreno-Bueno G, Acloque H, Vega S, et al. Metastatic Colonization Requires the Repression of the Epithelial-Mesenchymal Transition Inducer Prrx1. Cancer Cell. 2012; 22: 709-724. doi: 10.1016/j.ccr.2012.10.012 PMID: 23201163
25. Celià-Terrassa T, Meca-Cortés Ó, Mateo F, Martínez de Paz A, Rubio N, Arnal-Estapé A, et al. Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells. J Clin Invest. 2012; 122: 1849-1868. doi: 10.1172/JCI59218 PMID: 22505459
26. Tsai JH, Donaher JL, Murphy DA, Chau S, Yang J. Spatiotemporal Regulation of Epithelial-Mesenchymal Transition Is Essential for Squamous Cell Carcinoma Metastasis. Cancer Cell. 2012; 22: 725-736. doi: 10.1016/j.ccr.2012.09.022 PMID: 23201165
27. Tsuji T, Ibaragi S, Shima K, Hu MG, Katsurano M, Sasaki A, et al. Epithelial-Mesenchymal Transition Induced by Growth Suppressor p12CDK2-AP1 Promotes Tumor Cell Local Invasion but Suppresses Distant Colony Growth. Cancer Res. 2008; 68: 10377-10386. doi: 10.1158/0008-5472.CAN-08-1444 PMID: 19074907
28. Lu M, Jolly MK, Levine H, Onuchic JN, Ben-Jacob E. MicroRNA-based regulation of epithelial-hybridmesenchymal fate determination. Proc Natl Acad Sci. 2013; 110: 18144-18149. doi: 10.1073/pnas.1318192110 PMID: 24154725
29. Zhang J, Tian X-J, Zhang H, Teng Y, Li R, Bai F, et al. TGF - induced epithelial-to-mesenchymal transition proceeds through stepwise activation of multiple feedback loops. Sci Signal. 2014; 7: ra91-ra91. doi: 10.1126/scisignal.2005304 PMID: 25270257
30. Huang S, Guo Y-P, May G, Enver T. Bifurcation dynamics in lineage-commitment in bipotent progenitor cells. Dev Biol. 2007; 305: 695-713. doi: 10.1016/j.ydbio.2007.02.036 PMID: 17412320
31. Hu M, Krause D, Greaves M, Sharkis S, Dexter M, Heyworth C, et al. Multilineage gene expression precedes commitment in the hemopoietic system. Genes Dev. 1997; 11: 774-785. doi: 10.1101/gad.11.6.774 PMID: 9087431
32. Fillmore CM, Kuperwasser C. Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Res. 2008; 10: R25. doi: 10.1186/bcr1982 PMID: 18366788
33. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U A. 2003; 100: 3983-8. doi: 10.1073/pnas.0530291100 PMID: 12629218
34. Liu S, Cong Y, Wang D, Sun Y, Deng L, Liu Y, et al. Breast Cancer Stem Cells Transition between Epithelial and Mesenchymal States Reflective of their Normal Counterparts. Stem Cell Rep. 2014; 2: 78-91. doi: 10.1016/j.stemcr.2013.11.009
35. Strauss R, Li Z-Y, Liu Y, Beyer I, Persson J, Sova P, et al. Analysis of Epithelial and Mesenchymal Markers in Ovarian Cancer Reveals Phenotypic Heterogeneity and Plasticity. Gullberg D, editor. PLoS ONE. 2011; 6: e16186. doi: 10.1371/journal.pone.0016186 PMID: 21264259
36. Chaffer CL, Brueckmann I, Scheel C, Kaestli AJ, Wiggins PA, Rodrigues LO, et al. Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc Natl Acad Sci U S A. 2011; 108: 7950-7955. doi: 10.1073/pnas.1102454108 PMID: 21498687
37. Elenbaas B, Spirio L, Koerner F, Fleming MD, Zimonjic DB, Donaher JL, et al. Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev. 2001; 15: 50-65. PMID: 11156605
38. Loboda A, Nebozhyn MV, Watters JW, Buser CA, Shaw P, Huang PS, et al. EMT is the dominant program in human colon cancer. BMC Med Genomics. 2011; 4: 9. doi: 10.1186/1755-8794-4-9 PMID: 21251323
39. Ringnér M, Fredlund E, Häkkinen J, Borg Å, Staaf J. GOBO: Gene Expression-Based Outcome for Breast Cancer Online. Creighton C, editor. PLoS ONE. 2011; 6: e17911. doi: 10.1371/journal.pone.0017911 PMID: 21445301
40. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell. 2006; 10: 515-527. doi: 10.1016/j.ccr.2006.10.008 PMID: 17157791
41. Grimshaw MJ, Cooper L, Papazisis K, Coleman JA, Bohnenkamp HR, Chiapero-Stanke L, et al. Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells. Breast Cancer Res. 2008; 10: R52. doi: 10.1186/bcr2106 PMID: 18541018
42. Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D, et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res. 2005; 65: 5506-5511. doi: 10.1158/0008-5472.CAN-05-0626 PMID: 15994920
43. Györffy B, Lanczky A, Eklund AC, Denkert C, Budczies J, Li Q, et al. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res Treat. 2010; 123: 725-731. doi: 10.1007/s10549-009-0674-9 PMID: 20020197
44. Venet D, Dumont JE, Detours V. Most Random Gene Expression Signatures Are Significantly Associated with Breast Cancer Outcome. Rigoutsos I, editor. PLoS Comput Biol. 2011; 7: e1002240. doi: 10.1371/journal.pcbi.1002240 PMID: 22028643
45. Van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AAM, Mao M, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002; 415: 530-536. doi: 10.1038/415530a PMID: 11823860
46. Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A, et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet. 2008; 40: 499-507. doi: 10.1038/ng.127 PMID: 18443585
47. Marcus JS, Anderson WF, Quake SR. Microfluidic Single-Cell mRNA Isolation and Analysis. Anal Chem. 2006; 78: 3084-3089. doi: 10.1021/ac0519460 PMID: 16642997
48. Cleary AS, Leonard TL, Gestl SA, Gunther EJ. Tumour cell heterogeneity maintained by cooperating subclones in Wnt-driven mammary cancers. Nature. 2014; 508: 113-117. doi: 10.1038/nature13187 PMID: 24695311
49. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, et al. ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical Outcome. Cell Stem Cell. 2007; 1: 555-567. doi: 10.1016/j.stem.2007.08.014 PMID: 18371393
50. Azzam DJ, Zhao D, Sun J, Minn AJ, Ranganathan P, Drews-Elger K, et al. Triple negative breast cancer initiating cell subsets differ in functional and molecular characteristics and in γ-secretase inhibitor drug responses: Functional heterogeneity in breast CSCs. EMBO Mol Med. 2013; 5: 1502-1522. doi: 10.1002/emmm.201302558 PMID: 23982961
51. Bhat-Nakshatri P, Appaiah H, Ballas C, Pick-Franke P, Goulet R Jr, Badve S, et al. SLUG/SNAI2 and tumor necrosis factor generate breast cells with CD44+/CD24- phenotype. BMC Cancer. 2010; 10: 411. doi: 10.1186/1471-2407-10-411 PMID: 20691079
52. Zhang C, Li C, He F, Cai Y, Yang H. Identification of CD44+CD24+ gastric cancer stem cells. J Cancer Res Clin Oncol. 2011; 137: 1679-1686. doi: 10.1007/s00432-011-1038-5 PMID: 21882047
53. Montserrat N, Nivet E, Sancho-Martinez I, Hishida T, Kumar S, Miquel L, et al. Reprogramming of Human Fibroblasts to Pluripotency with Lineage Specifiers. Cell Stem Cell. 2013; 13: 341-350. doi: 10.1016/j.stem.2013.06.019 PMID: 23871606
54. Lu M, Jolly MK, Onuchic J, Ben-Jacob E. Toward decoding the principles of cancer metastasis circuits. Cancer Res. 2014; 74: 4574-4587. doi: 10.1158/0008-5472.CAN-13-3367 PMID: 25183783
55. Jolly MK, Huang B, Lu M, Mani SA, Levine H, Ben-Jacob E. Towards elucidating the connection between epithelial-mesenchymal transitions and stemness. J R Soc Interface R Soc. 2014; 11: 20140962. doi: 10.1098/rsif.2014.0962 PMID: 25339690
56. Tian X-J, Zhang H, Xing J. Coupled Reversible and Irreversible Bistable Switches Underlying TGFβ-induced Epithelial to Mesenchymal Transition. Biophys J. 2013; 105: 1079-1089. doi: 10.1016/j.bpj.2013.07.011 PMID: 23972859
57. Zhou JX, Huang S. Understanding gene circuits at cell-fate branch points for rational cell reprogramming. Trends Genet. 2011; 27: 55-62. doi: 10.1016/j.tig.2010.11.002 PMID: 21146896
58. Niwa H, Miyazaki J, Smith AG. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet. 2000; 24: 372-376. doi: 10.1038/74199 PMID: 10742100
59. Samavarchi-Tehrani P, Golipour A, David L, Sung H, Beyer TA, Datti A, et al. Functional Genomics Reveals a BMP-Driven Mesenchymal-to-Epithelial Transition in the Initiation of Somatic Cell Reprogramming. Cell Stem Cell. 2010; 7: 64-77. doi: 10.1016/j.stem.2010.04.015 PMID: 20621051
60. Li R, Liang J, Ni S, Zhou T, Qing X, Li H, et al. A Mesenchymal-to-Epithelial Transition Initiates and Is Required for the Nuclear Reprogramming of Mouse Fibroblasts. Cell Stem Cell. 2010; 7: 51-63. doi: 10.1016/j.stem.2010.04.014 PMID: 20621050
61. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006; 126: 663-676. doi: 10.1016/j.cell.2006.07.024 PMID: 16904174
62. Ombrato L, Malanchi I. The EMT universe: space between cancer cell dissemination and metastasis initiation. Crit Rev Oncog. 2014; 19: 349-361. PMID: 25404150
63. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest. 2009; 119: 1420-8. doi: 10.1172/JCI39104 PMID: 19487818
64. Aceto N, Bardia A, Miyamoto DT, Donaldson MC, Wittner BS, Spencer JA, et al. Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis. Cell. 2014; 158: 1110-1122. doi: 10.1016/j.cell.2014.07.013 PMID: 25171411
65. Yu M, Bardia A, Wittner BS, Stott SL, Smas ME, Ting DT, et al. Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition. Science. 2013; 339: 580-584. doi: 10.1126/science.1228522 PMID: 23372014
66. Baccelli I, Schneeweiss A, Riethdorf S, Stenzinger A, Schillert A, Vogel V, et al. Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. Nat Biotechnol. 2013; 31: 539-544. doi: 10.1038/nbt.2576 PMID: 23609047
67. Mihály Z, Gyo{combining double acute accent}rffy B. Improving Pathological Assessment of Breast Cancer by Employing Array-Based Transcriptome Analysis. Microarrays. 2013; 2: 228-242. doi: 10.3390/microarrays2030228
68. Li Q, Birkbak NJ, Gyorffy B, Szallasi Z, Eklund AC. Jetset: selecting the optimal microarray probe set to represent a gene. BMC Bioinformatics. 2011; 12: 474. doi: 10.1186/1471-2105-12-474 PMID: 22172014